$12.8 Million Settlement Pending In KV Pharmaceutical Class-Action Suit

Published: Mar 06, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The bankrupt KV Pharmaceutical Co. has agreed to a pay a proposed $12.8 million to settle a class-action lawsuit. The settlement with lead plaintiffs Norfolk County Retirement System and the State-Boston Retirement System received preliminary approval in January from Judge Carol Jackson of the U.S. District Court for the Eastern District of Missouri. A settlement hearing is scheduled for April 23. The lawsuit alleges that KV made misstatements and omissions regarding its compliance with the FDA and with good manufacturing practices, according to a statement from Labaton Sucharow, the New York law firm representing the plaintiffs.

Help employers find you! Check out all the jobs and post your resume.

Back to news